Acceptability, adherence, and clinical outcomes, of amoxicillin dispersible tablets versus oral suspension in treatment of children aged 2-59 Months with pneumonia, Kenya: A cluster randomized controlled trial

被引:8
|
作者
Angwa, Linet M. [1 ]
Ouma, Collins [2 ]
Okoth, Peter [3 ]
Nyamai, Rachel [4 ]
Kamau, Nyawira G. [5 ]
Mutai, Kennedy [6 ]
Onono, Maricianah A. [7 ]
机构
[1] Kabarak Univ, Dept Clin Med, Nakuru, Kenya
[2] Maseno Univ, Dept Biomed Sci & Technol, Kisumu, Kenya
[3] UNICEF Kenya Country Off, Kisumu, Kenya
[4] Minist Hlth, Nairobi, Kenya
[5] Jomo Kenyatta Univ, Inst Trop Med, Juja, Kenya
[6] Natl AIDS Control Council, Nairobi, Kenya
[7] Kenya Govt Med Res Ctr, Ctr Microbiol, Nairobi, Kenya
关键词
Health sciences; Public health; Infectious disease; Clinical research; Acceptability; Adherence; Pneumonia; Dispersible tablets; Oral suspension; COMMUNITY CASE-MANAGEMENT; YOUNG-CHILDREN; ACCURACY; DEVICES; BLIND;
D O I
10.1016/j.heliyon.2020.e03786
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Amoxicillin dispersible tablet (DT) is now recommended by the WHO as a first-line drug for the treatment of pneumonia in children below 5 years. The study aim was to compare acceptability, adherence and clinical outcome of amoxicillin DT and amoxicillin oral suspension (OS) in the treatment of children aged 2-59 months with pneumonia in Kenya. We conducted a two-arm cluster randomized controlled trial and utilized quantitative methods. The community unit was the unit of randomization. Children aged 2-59 months with pneumonia were enrolled and treated with either amoxicillin DT or OS. Acceptability was defined as the perception of taste of medication as the same or better compared to other medicines and expression of willingness of caregivers to use DT/OS in future, adherence was measured based on the dose, frequency, and duration of treatment, and clinical outcome as complete resolution of symptoms without change of antibiotic treatment. Equivalence was defined as a difference of <= 8% between study arms. We found high levels of acceptability among both DT (93.9%) and OS (96.1%) arms (difference 2.3%, 90% CI -2.6-7.3). The objective measure of adherence on day four and the overall objective measure were significantly higher among children on DT compared to children on OS (88.7% vs. 41.5% (difference 47.2%, 90% CI 31.0-63.3) & 83.5% vs. 39% (difference 44.5%, 90% CI 27.9-60.9), respectively). Cure rates were high in both arms (DT (99.5%), OS (98.1%), difference 1.4%, 90% CI -0.2-3.2). There is reported better adherence to Amoxicillin DT compared to OS and equivalence in acceptability and clinical outcomes.
引用
收藏
页数:6
相关论文
共 31 条
  • [1] Community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Haripur district, Pakistan: a cluster randomised trial
    Bari, Abdul
    Sadruddin, Salim
    Khan, Attaullah
    Khan, Ibad ul Haque
    Khan, Amanullah
    Lehri, Iqbal A.
    Macleod, William B.
    Fox, Matthew P.
    Thea, Donald M.
    Qazi, Shamim A.
    [J]. LANCET, 2011, 378 (9805): : 1796 - 1803
  • [2] Effectiveness of community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Matiari district, rural Pakistan: a cluster-randomised controlled trial
    Soofi, Sajid
    Ahmed, Sheraz
    Fox, Matthew P.
    MacLeod, William B.
    Thea, Donald M.
    Qazi, Shamim A.
    Bhutta, Zulfiqar A.
    [J]. LANCET, 2012, 379 (9817): : 729 - 737
  • [3] METHODS OF A DOUBLE-BLIND RANDOMIZED CONTROLLED CLINICAL TRIAL OF THREE VERSUS FIVE DAYS AMOXICILLIN DISPERSIBLE TABLETS FOR CHEST-INDRAWING PNEUMONIA AMONG CHILDREN 2-59 MONTHS OF AGE PRESENTING TO KAMUZU CENTRAL HOSPITAL IN LILONGWE, MALAWI
    Ambler, Gwen
    Sadruddin, Salim
    Phiri, Ajib
    Lufesi, Norman
    Chimuna, Tiyese
    May, Susanne
    Ginsburg, Amy
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2015, 93 (04): : 344 - 344
  • [4] A double blind community-based randomized trial of amoxicillin versus placebo for fast breathing pneumonia in children aged 2-59 months in Karachi, Pakistan (RETAPP)
    Jehan, Fyezah
    Nisar, Muhammad Imran
    Kerai, Salima
    Brown, Nick
    Balouch, Benazir
    Hyder, Zulfiqar
    Ambler, Gwen
    Ginsburg, Amy Sarah
    Zaidi, Anita K. M.
    [J]. BMC INFECTIOUS DISEASES, 2016, 16
  • [5] A double blind community-based randomized trial of amoxicillin versus placebo for fast breathing pneumonia in children aged 2-59 months in Karachi, Pakistan (RETAPP)
    Fyezah Jehan
    Muhammad Imran Nisar
    Salima Kerai
    Nick Brown
    Benazir Balouch
    Zulfiqar Hyder
    Gwen Ambler
    Amy Sarah Ginsburg
    Anita K. M. Zaidi
    [J]. BMC Infectious Diseases, 16
  • [6] Comparison of Oral Amoxicillin with Placebo for the Treatment of World Health Organization-Defined Nonsevere Pneumonia in Children Aged 2-59 Months: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial in Pakistan
    Hazir, Tabish
    Bin Nisar, Yasir
    Abbasi, Saleem
    Ashraf, Yusra Pervaiz
    Khurshid, Joza
    Tariq, Perveen
    Asghar, Rai
    Murtaza, Asifa
    Masood, Tahir
    Maqbool, Sajid
    [J]. CLINICAL INFECTIOUS DISEASES, 2011, 52 (03) : 293 - 300
  • [7] A randomized controlled trial of hospital versus home based therapy with oral amoxicillin for severe pneumonia in children aged 3 – 59 months: The IndiaCLEN Severe Pneumonia Oral Therapy (ISPOT) Study
    Archana B. Patel
    Akash Bang
    Meenu Singh
    Leena Dhande
    Luke Ravi Chelliah
    Ashraf Malik
    Sandhya Khadse
    [J]. BMC Pediatrics, 15
  • [8] Comparison of 3 Days Amoxicillin Versus 5 Days Co-Trimoxazole for Treatment of Fast-breathing Pneumonia by Community Health Workers in Children Aged 2-59 Months in Pakistan: A Cluster-randomized Trial
    Sadruddin, Salim
    Khan, Ibad ul Haque
    Fox, Matthew P.
    Bari, Abdul
    Khan, Attaullah
    Thea, Donald M.
    Khan, Amanullah
    Khan, Inamullah
    Ahmad, Ijaz
    Qazi, Shamim A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2019, 69 (03) : 397 - 404
  • [9] Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2-59 months: a multi-centre, double blind, randomised controlled trial in Pakistan
    Hazir, Tabish
    Qazi, Shamim A.
    Bin Nisar, Yasir
    Maqbool, Sajid
    Asghar, Rai
    Iqbal, Imran
    Khalid, Sobia
    Randhawa, Sajid
    Aslam, Shazia
    Riaz, Sobia
    Abbasi, Saleem
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2007, 92 (04) : 291 - 297
  • [10] Injectable Amoxicillin Versus Injectable Ampicillin Plus Gentamicin in the Treatment of Severe Pneumonia in Children Aged 2 to 59 Months: Protocol for an Open-Label Randomized Controlled Trial
    Shahrin, Lubaba
    Chisti, Mohammod Jobayer
    Bin Shahid, Abu Sadat Mohammad Sayeem
    Rahman, Abu Sayem Mirza Mohammad Hasibur
    Islam, Md. Zahidul
    Afroze, Farzana
    Huq, Sayeeda
    Ahmed, Tahmeed
    [J]. JMIR RESEARCH PROTOCOLS, 2020, 9 (11):